Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 27.24
+1.75 (6.87%)
Sep 30, 2026, 3:00 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 14.08 billion as of October 2, 2026. Its market cap has increased by 53.68% in one year.
Market Cap
14.08B
Enterprise Value
12.24B
Revenue
1.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
27.24
ChartMarket Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 14.08B, a decrease of -58.75%. That is a compound annual growth rate of -16.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 14.08B | 76.86% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 17.43B |
| BrightGene Bio-Medical Technology | 15.59B |
| GemPharmatech | 15.52B |
| Anhui Anke Biotechnology (Group) | 14.35B |
| Shanghai Medicilon | 14.16B |
| Jinyu Bio-technology | 12.65B |
| Chengdu Olymvax Biopharmaceuticals | 12.65B |
| Inner Mongolia Furui Medical Science | 12.44B |